Chemours Co — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2021-03-01

Reporting Person: Kelliher Susan M. (SVP, People & Health Services)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	A	2915	—	Acquired	37586.3012	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-01	Stock Option (Right to Buy)	$24.01	A	28629	Acquired	2031-03-01	Common Stock (28629)	Direct

Footnotes

F1: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2022.

F2: Includes directly owned shares, restricted stock units and dividend equivalent units.

F3: These options are scheduled to vest in three equal annual installments beginning on March 1, 2022.